A new trading day began on Tuesday, with Century Therapeutics Inc (NASDAQ: IPSC) stock price up 5.56% from the previous day of trading, before settling in for the closing price of $1.26. IPSC’s price has ranged from $1.14 to $5.51 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -14.25% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 24.11%. With a float of $34.24 million, this company’s outstanding shares have now reached $60.34 million.
In an organization with 165 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -488.98%, operating margin of -6517.58%, and the pretax margin is -6446.67%.
Century Therapeutics Inc (IPSC) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Century Therapeutics Inc is 59.58%, while institutional ownership is 28.87%. The most recent insider transaction that took place on Nov 04 ’24, was worth 1,267. In this transaction Chief Operations Officer of this company sold 1,033 shares at a rate of $1.23, taking the stock ownership to the 135,130 shares. Before that another transaction happened on Nov 04 ’24, when Company’s SVP Finance & Operations sold 283 for $1.23, making the entire transaction worth $347. This insider now owns 317,147 shares in total.
Century Therapeutics Inc (IPSC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 24.11% per share during the next fiscal year.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Here are Century Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.04, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.85 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.56 million. That was better than the volume of 0.26 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.04%. Additionally, its Average True Range was 0.13.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 8.80%, which indicates a significant decrease from 37.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.24% in the past 14 days, which was lower than the 89.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5303, while its 200-day Moving Average is $2.8438. However, in the short run, Century Therapeutics Inc’s stock first resistance to watch stands at $1.4233. Second resistance stands at $1.5167. The third major resistance level sits at $1.6033. If the price goes on to break the first support level at $1.2433, it is likely to go to the next support level at $1.1567. The third support level lies at $1.0633 if the price breaches the second support level.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
With a market capitalization of 112.67 million, the company has a total of 84,716K Shares Outstanding. Currently, annual sales are 2,240 K while annual income is -136,670 K. The company’s previous quarter sales were 770 K while its latest quarter income was -31,210 K.
